• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder.比较当前或过去患有重度抑郁症的吸烟者尼古丁代谢率。
Am J Addict. 2021 Jul;30(4):382-388. doi: 10.1111/ajad.13155. Epub 2021 Mar 26.
2
Tobacco Withdrawal Symptoms Before and After Nicotine Deprivation in Veteran Smokers with Posttraumatic Stress Disorder and with Major Depressive Disorder.创伤后应激障碍和重性抑郁障碍退伍吸烟者在尼古丁剥夺前后的戒烟症状。
Nicotine Tob Res. 2021 Jun 8;23(7):1239-1247. doi: 10.1093/ntr/ntaa242.
3
Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.在一个以社区为基础的寻求治疗的吸烟者样本中尼古丁代谢率与戒烟结果
Addict Behav. 2015 Dec;51:93-9. doi: 10.1016/j.addbeh.2015.07.019. Epub 2015 Jul 26.
4
Evaluation of smokers with and without asthma in terms of smoking cessation outcome, nicotine withdrawal symptoms, and craving: Findings from a self-guided quit attempt.对有哮喘和无哮喘的吸烟者在戒烟结果、尼古丁戒断症状及烟瘾方面的评估:来自一次自我引导式戒烟尝试的结果
Addict Behav. 2016 Dec;63:149-54. doi: 10.1016/j.addbeh.2016.07.021. Epub 2016 Aug 1.
5
Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.尼古丁含片对情感性戒烟戒断症状的影响:一项随机、双盲、安慰剂对照临床试验的二次分析
Clin Ther. 2008 Aug;30(8):1461-75. doi: 10.1016/j.clinthera.2008.07.019.
6
Smoking history, nicotine dependence, and changes in craving and mood during short-term smoking abstinence in alcohol dependent vs. control smokers.吸烟史、尼古丁依赖以及在酒精依赖和对照吸烟者短期戒烟期间的渴求感和情绪变化。
Addict Behav. 2011 Mar;36(3):244-7. doi: 10.1016/j.addbeh.2010.10.008. Epub 2010 Oct 28.
7
Clinical significance of early smoking withdrawal effects and their relationships with nicotine metabolism: preliminary results from a pilot study.早期戒烟效果的临床意义及其与尼古丁代谢的关系:一项初步研究的初步结果
Nicotine Tob Res. 2014 May;16(5):615-20. doi: 10.1093/ntr/ntt204. Epub 2013 Dec 18.
8
Differences in the rate of nicotine metabolism among smokers with and without HIV.吸烟者中 HIV 感染者与非感染者之间尼古丁代谢率的差异。
AIDS. 2019 May 1;33(6):1083-1088. doi: 10.1097/QAD.0000000000002127.
9
Intolerance for smoking abstinence among nicotine-deprived, treatment-seeking smokers.对尼古丁依赖、寻求治疗的吸烟者戒烟不能耐受。
Addict Behav. 2018 Sep;84:13-19. doi: 10.1016/j.addbeh.2018.03.019. Epub 2018 Mar 20.
10
Single versus recurrent depression history: differentiating risk factors among current US smokers.单次或多次抑郁史:当前美国吸烟者的风险因素差异。
Drug Alcohol Depend. 2010 Jun 1;109(1-3):90-5. doi: 10.1016/j.drugalcdep.2009.12.020. Epub 2010 Jan 13.

引用本文的文献

1
Baseline predictors of smoking cessation among individuals with current or past major depressive disorder following treatment with varenicline and intensive behavioral treatment.在接受伐尼克兰治疗和强化行为治疗后,患有当前或既往重度抑郁症的个体戒烟的基线预测因素。
Drug Alcohol Depend. 2025 Sep 1;274:112761. doi: 10.1016/j.drugalcdep.2025.112761. Epub 2025 Jun 21.

本文引用的文献

1
Trends in the Prevalence of Current, Daily, and Nondaily Cigarette Smoking and Quit Ratios by Depression Status in the U.S.: 2005-2017.美国 2005-2017 年按抑郁状况划分的当前、每日和非每日吸烟流行趋势及戒烟率。
Am J Prev Med. 2020 May;58(5):691-698. doi: 10.1016/j.amepre.2019.12.023. Epub 2020 Mar 7.
2
The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions.尼古丁代谢物比值作为生物标志物用于个性化戒烟治疗:当前证据与未来方向。
Cancer Prev Res (Phila). 2020 Mar;13(3):261-272. doi: 10.1158/1940-6207.CAPR-19-0259.
3
Differences in the rate of nicotine metabolism among smokers with and without HIV.吸烟者中 HIV 感染者与非感染者之间尼古丁代谢率的差异。
AIDS. 2019 May 1;33(6):1083-1088. doi: 10.1097/QAD.0000000000002127.
4
Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies.倾向评分法与协变量调整的比较:4 项心血管研究中的评估。
J Am Coll Cardiol. 2017 Jan 24;69(3):345-357. doi: 10.1016/j.jacc.2016.10.060.
5
Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting.应用药代动力学/药物遗传学方法评估现实生活中吸烟者的尼古丁代谢概况。
J Pharm Biomed Anal. 2016 Nov 30;131:208-213. doi: 10.1016/j.jpba.2016.08.041. Epub 2016 Aug 31.
6
Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio.烟草依赖的精准医学:尼古丁代谢物比率的开发与验证
J Neuroimmune Pharmacol. 2016 Sep;11(3):471-83. doi: 10.1007/s11481-016-9656-y. Epub 2016 Feb 12.
7
Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation.不同分析方法和实验室检测血浆及尿液中尼古丁代谢物比率(3-羟基可替宁/可替宁)的情况:对临床应用的启示
Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1239-46. doi: 10.1158/1055-9965.EPI-14-1381. Epub 2015 May 26.
8
A 2015 Update on The Natural History and Diagnosis of Nicotine Addiction.《尼古丁成瘾的自然史与诊断2015年更新》
Curr Pediatr Rev. 2015;11(1):43-55. doi: 10.2174/1573396311666150501002703.
9
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.使用尼古丁代谢物比率作为对尼古丁贴片或伐尼克兰戒烟反应的遗传信息生物标志物:一项随机、双盲、安慰剂对照试验。
Lancet Respir Med. 2015 Feb;3(2):131-138. doi: 10.1016/S2213-2600(14)70294-2. Epub 2015 Jan 12.
10
Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers.大量寻求治疗的吸烟者中尼古丁代谢物比率变异性的已知和新来源。
Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1773-82. doi: 10.1158/1055-9965.EPI-14-0427. Epub 2014 Jul 10.

比较当前或过去患有重度抑郁症的吸烟者尼古丁代谢率。

Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder.

机构信息

Department of Psychiatry, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.

Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

Am J Addict. 2021 Jul;30(4):382-388. doi: 10.1111/ajad.13155. Epub 2021 Mar 26.

DOI:10.1111/ajad.13155
PMID:33772971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8243789/
Abstract

BACKGROUND AND OBJECTIVES

Persons with current or past major depressive disorder (MDD) vs those without have higher smoking rates. The nicotine metabolite ratio (NMR) represents variation in the rate of nicotine metabolism and has been associated with smoking behaviors and response to tobacco treatments. We compared NMR between smokers with current or past MDD (MDD+) vs smokers without MDD (MDD-). We also assessed correlates of NMR and compared withdrawal and craving between MDD+ and MDD- smokers.

METHODS

Using baseline data from two clinical trials and propensity score weighting based on sex, race, body mass index, and smoking rate, we compared NMR between MDD+ (N = 279) and MDD- (N = 1575) smokers. We also compared groups on and nicotine withdrawal and craving.

RESULTS

Mean NMR (β = -.02, 95% confidence interval [CI]: -0.05 to 0.01, P = .13) and the distribution of smokers across NMR quartiles (odds ratio [OR] = 0.76, 95% CI: 0.50 to 1.16, P = .21) were similar between MDD+ and MDD- samples. This relationship was not affected by antidepressant medication. In the MDD+ sample, African Americans had significantly lower mean NMR, while older smokers and smokers with lower education had higher mean NMR (Ps < .05). MDD+ smokers had significantly higher withdrawal and craving than MDD- smokers (Ps < .05).

DISCUSSION AND CONCLUSIONS

While variability in NMR may not explain differences in smoking rates between MDD+ and MDD- smokers, MDD+ smokers report increased withdrawal and craving.

SCIENTIFIC SIGNIFICANCE

In this first study to assess NMR among MDD+ smokers, the findings underscore the need to address withdrawal and craving within smoking cessation treatments for those with MDD. (Am J Addict 2021;00:00-00).

摘要

背景与目的

当前或过去患有重度抑郁症(MDD)的人与没有 MDD 的人相比,吸烟率更高。尼古丁代谢率比值(NMR)代表尼古丁代谢率的变化,与吸烟行为和对烟草治疗的反应有关。我们比较了当前或过去患有 MDD(MDD+)的吸烟者与没有 MDD(MDD-)的吸烟者之间的 NMR。我们还评估了 NMR 的相关性,并比较了 MDD+和 MDD-吸烟者的戒断和渴望程度。

方法

使用两项临床试验的基线数据,并根据性别、种族、体重指数和吸烟率进行倾向评分加权,我们比较了 MDD+(N=279)和 MDD-(N=1575)吸烟者之间的 NMR。我们还比较了两组的尼古丁戒断和渴望程度。

结果

平均 NMR(β=-0.02,95%置信区间[CI]:-0.05 至 0.01,P=0.13)和 NMR 四分位数分布的吸烟者(优势比[OR]=0.76,95%CI:0.50 至 1.16,P=0.21)在 MDD+和 MDD-样本之间相似。这种关系不受抗抑郁药物的影响。在 MDD+样本中,非裔美国人的平均 NMR 明显较低,而年龄较大的吸烟者和受教育程度较低的吸烟者的平均 NMR 较高(P<0.05)。MDD+吸烟者的戒断和渴望程度明显高于 MDD-吸烟者(P<0.05)。

讨论与结论

尽管 NMR 的变异性可能无法解释 MDD+和 MDD-吸烟者之间吸烟率的差异,但 MDD+吸烟者报告戒断和渴望程度增加。

科学意义

在这项评估 MDD+吸烟者 NMR 的首次研究中,研究结果强调了在针对 MDD 的戒烟治疗中需要解决戒断和渴望问题。